Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Brain Stimulation May Help with Fibromyalgia

Lara C. Pullen, PhD  |  April 3, 2017

Patients with fibromyalgia often have cognitive dysfunction that appears to result from a reduced capacity to maintain the endogenous level of brain activation necessary to perform a task. This deficiency can be particularly obvious when attentional demands are increased, suggesting that patients with fibromyalgia have a reduced ability to filter distracting information. The combination of impaired sustained attention and reduced processing speed can, therefore, compromise cognitive performance in this patient population. Although these observations have been made in multiple studies, the underlying mechanisms behind the cognitive dysfunctions seen in fibromyalgia have not been well explained.

Researchers have investigated the ability of transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex (DLPFC) to modulate attention in patients with fibromyalgia. The approach has been effective, possibly because the DLPFC influences cognitive-executive control and the descendent pain modulation system. Adriana Ferreira Silva, a graduate student at the Federal University of Rio Grande do Sul in Brazil, and colleagues published the results of their investigation of tDCS over the DLPFC in patients with fibromyalgia and published the results online March 9 in Scientific Reports.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators tested the effects of a single, uniform dose of tDCS (anodal stimulation of 1 mA for 20 minutes) coupled with a go/no-go task in modulating alerting, orienting and executive attention indices. They randomly allocated 20 patients to the sequence sham-active group and another 20 to the sequence active-sham group. The researchers measured attention using the Attention Network Test. While acknowledging that this uniform dosage may not be optimal for all patients, the team notes that a single session of anodal tDCS over the left DLPFC had a modulatory effect on the orienting and executive attentional networks. They did not, however, see any effect on alertness.

The study also examined, as its secondary outcome, the effect of anodal tDCS over left DLPFC on heat pain threshold and heat pain tolerance. The investigators found that active tDCS increased heat pain threshold as compared with sham and heat pain tolerance. They then sought to better understand the relationship of Attention Network Test scores with pain measures. When the researchers performed a regression analysis, they found the effect on executive attention appeared to be largely independent of the effect on pain. This was true even though tDCS influences pain and attention in fibromyalgia.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Taken together, the research suggests that both DLPFC and primary motor cortex may be important targets for neurostimulation, particularly for patients who do not respond adequately to standard neurostimulation therapies.

Page: 1 2 | Single Page
Share: 

Filed under:Conditions

Related Articles

    Is Acupuncture for Pain a Placebo Treatment?

    November 1, 2010

    An examination of the evidence

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    How Depression Affects the Cognitive Profile of Fibromyalgia Patients

    July 23, 2018

    New research evaluated the effect of depression on the cognition of fibromyalgia patients, finding that these patients have a distinct cognitive profile. Researchers note that emotional symptoms, such as depression and anxiety, are essential to the cognitive performance of fibromyalgia patients and that treating these symptoms may reduce cognitive impairment…

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences